SLGL News and Press, Sol-Gel Technologies Ltd. From 07/08/19

Ultra-thinly traded micro cap Sol-Gel Technologies ( SLGL +13.1% ) is up on almost a 19x surge in volume, albeit on turnover of only 267K shares, in response to positive results from two Phase 3 clinical trials, SGT 54-01 and SGT 54-02 , evaluating Epsolay microencapsulated benzoyl pe...

All primary and secondary endpoints achieved in both Phase 3 clinical trials Rapid efficacy demonstrated, with statistical significance reached as early as Week 2 compared with vehicle Favorable safety and tolerability profile, similar to vehicle Conference call and webcast toda...

Sol-Gel Technologies ( SLGL +1.6% ) has consummated its seventh collaboration agreement with Perrigo ( PRGO +1.7% ), this one aimed at the development, manufacture and commercialization of two new generic antibiotic foams. More news on: Sol-Gel Technologies Ltd., Perrigo Company plc,...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you ca...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...

The following slide deck was published by Sol-Gel Technologies Ltd. in conjunction with this Read more ...

NESS ZIONA, Israel, June 17, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for...

The following slide deck was published by Sol-Gel Technologies Ltd. in conjunction with this Read more ...

NESS ZIONA, Israel, May 28, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for ...

NESS ZIONA, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for ...